Muscle functional capacity (MFC)

Muscle functional capacity refers to the integrated ability of the skeletal muscle system to perform work and physical tasks, encompassing components such as strength, power, and endurance. It is not a specific molecular entity or receptor but is instead a physiological phenotype and a critical clinical endpoint used to evaluate the efficacy of therapies for muscle-wasting conditions and aging (PMID: 30043140). In a therapeutic context, muscle functional capacity represents the 'output' of various molecular pathways, including those regulated by myostatin, insulin-like growth factor 1 (IGF-1), and androgen receptors. Diminished capacity is a hallmark of sarcopenia, cachexia, and various neuromuscular diseases, where it serves as a primary predictor of disability and mortality (StatPearls: Sarcopenia). Because it involves the coordination of neuromuscular, respiratory, and cardiovascular systems, it is assessed through standardized performance tests like the six-minute walk test rather than molecular binding assays. Drug development programs often target specific proteins to ultimately manifest an improvement in this aggregate functional measure.

Other names

Muscle functionPhysical functional capacityExercise capacitySkeletal muscle performanceMuscular strength and endurance

Muscle functional capacity is a clinical endpoint rather than a molecular target. Drugs intended to improve this capacity work through various mechanisms such as Myostatin (GDF-8) inhibition, Selective Androgen Receptor Modulation (SARM), or stimulation of mitochondrial biogenesis to increase muscle mass and quality (PMID: 29165172; NIH: ClinicalTrials.gov).